Search research articles
Contact Us
Filters
Showing results (101-110 of 133) with videos related to
Page
of 14
Sort By:
Annals of Hematology
|
October 5, 2017
A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry
Brett L Houston, Jennifer Jayakar, Richard A Wells, et al.
British Journal of Haematology
|
March 19, 2016
Patient-related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS-CAN prospective study
Rena Buckstein, Richard A Wells, Nancy Zhu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2015
Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study
Laurie H Sehn, Andre Goy, Fritz C Offner, et al.
Plos One
|
March 30, 2021
Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review
Yaping Chang, Gordon H Guyatt, Trevor Teich, et al.
Blood Cancer Journal
|
December 31, 2025
Effect of prior therapy on the clinical activity of imetelstat in patients with transfusion-dependent, ESA-relapsed or -refractory/-ineligible LR-MDS
Rami S Komrokji, Valeria Santini, Amer M Zeidan, et al.
Nature Communications
|
May 22, 2026
Initial leukemic epigenomic state determines hypomethylating agent response
Aparna Gopal, Derek Tam, Franziska Mey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 22, 2014
Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma
Diego Villa, Anupkumar George, John F Seymour, et al.
Blood
|
July 7, 2022
Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts
Amer M Zeidan, Uwe Platzbecker, Guillermo Garcia-Manero, et al.
British Journal of Haematology
|
June 1, 2021
Patient-reported fatigue refines prognosis in higher-risk myelodysplastic syndromes (MDS): a MDS-CAN study
Irina Amitai, Michelle Geddes, Nancy Zhu, et al.
Blood Advances
|
August 8, 2020
American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults
Mikkael A Sekeres, Gordon Guyatt, Gregory Abel, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 133) with videos related to
Sort By:
Page
of 14
Annals of Hematology
|
October 5, 2017
A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry
Brett L Houston, Jennifer Jayakar, Richard A Wells, et al.
British Journal of Haematology
|
March 19, 2016
Patient-related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS-CAN prospective study
Rena Buckstein, Richard A Wells, Nancy Zhu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2015
Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study
Laurie H Sehn, Andre Goy, Fritz C Offner, et al.
Plos One
|
March 30, 2021
Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review
Yaping Chang, Gordon H Guyatt, Trevor Teich, et al.
Blood Cancer Journal
|
December 31, 2025
Effect of prior therapy on the clinical activity of imetelstat in patients with transfusion-dependent, ESA-relapsed or -refractory/-ineligible LR-MDS
Rami S Komrokji, Valeria Santini, Amer M Zeidan, et al.
Nature Communications
|
May 22, 2026
Initial leukemic epigenomic state determines hypomethylating agent response
Aparna Gopal, Derek Tam, Franziska Mey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 22, 2014
Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma
Diego Villa, Anupkumar George, John F Seymour, et al.
Blood
|
July 7, 2022
Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts
Amer M Zeidan, Uwe Platzbecker, Guillermo Garcia-Manero, et al.
British Journal of Haematology
|
June 1, 2021
Patient-reported fatigue refines prognosis in higher-risk myelodysplastic syndromes (MDS): a MDS-CAN study
Irina Amitai, Michelle Geddes, Nancy Zhu, et al.
Blood Advances
|
August 8, 2020
American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults
Mikkael A Sekeres, Gordon Guyatt, Gregory Abel, et al.
Page
of 14